Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Also known as: Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00002 | Cetuximab | 1 | Completed | 2 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Withdrawn | 1 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB12304 | Entolimod | 1 | Withdrawn | 1 |
| DB01590 | Everolimus | 1 | Completed | 1 |
| DB16555 | Lactoferrin | 1 | Terminated | 1 |
| DB12303 | Motolimod | 1 | Completed | 1 |
| DB00398 | Sorafenib | 1 | Completed | 1 |
| DB11666 | Buparlisib | 1 / 2 | Completed | 1 |
| DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB02546 | Vorinostat | 1 / 2 | Completed | 1 |
| DB11740 | Adavosertib | 2 | Terminated | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
| DB00002 | Cetuximab | 2 | Completed | 3 |
| DB14547 | Chloride ion | 2 | Terminated | 1 |
| DB00515 | Cisplatin | 2 | Terminated | 1 |
| DB01254 | Dasatinib | 2 | Completed | 1 |
| DB11680 | Ficlatuzumab | 2 | Completed | 1 |
| DB00762 | Irinotecan | 2 | Completed | 1 |
| DB06188 | Ispinesib | 2 | Completed | 1 |
| DB04845 | Ixabepilone | 2 | Completed | 1 |
| DB01259 | Lapatinib | 2 | Completed | 1 |
| DB03010 | Patupilone | 2 | Completed | 1 |
| DB12257 | Platinum | 2 | Terminated | 1 |
| DB11805 | Saracatinib | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 2 |
| DB06287 | Temsirolimus | 2 | Completed | 1 |
| DB00317 | Gefitinib | Not Available | Completed | 1 |